Effects of Diet and Gemfibrozil on Posttransplant Hyperlipidemia in Renal Transplant Recipients

sapan M., ÖZBEN SADIÇ B., yakupoğlu G., SÜLEYMANLAR G., Ozben T.

JOURNAL OF INVESTIGATIVE MEDICINE, cilt.57, sa.2, ss.456-459, 2009 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 57 Sayı: 2
  • Basım Tarihi: 2009
  • Doi Numarası: 10.2310/jim.0b013e318197da68
  • Dergi Adı: JOURNAL OF INVESTIGATIVE MEDICINE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.456-459
  • Anahtar Kelimeler: Gemfibrozil, hyperlipidemia, renal transplantation, American phase 3 diet, DENSITY-LIPOPROTEIN CHOLESTEROL, CORONARY-ARTERY-DISEASE, RANDOMIZED CONTROLLED-TRIAL, SECONDARY PREVENTION, OXIDATIVE STRESS, KIDNEY-TRANSPLANTATION, CARDIOVASCULAR-DISEASE, MYOCARDIAL-INFARCTION, DIABETES-MELLITUS, HDL CHOLESTEROL
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Background: Posttransplant hyperlipidemia increases cardiovascular morbidity and mortality rate in renal transplant recipients. It also leads, to graft loss due to atherosclerosis and glomerular damage. It is essential to control hyperlipidemia in renal transplant recipients to prevent these events.